Statement Of Cash Flows [Abstract]

Sopharma AD - Filing #6175083

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Income taxes paid, classified as operating activities
9 905 BGN
7 937 BGN
Income taxes refund, classified as operating activities
49,000 BGN
43,000 BGN
Cash flows from (used in) investing activities [abstract]
Dividends received from associates, classified as investing activities
1 215 BGN
- BGN
Proceeds from sales of interests in associates
- BGN
213,000 BGN
Purchase of interests in investments accounted for using equity method
16 480 BGN
20 800 BGN
Cash advances and loans made to related parties
13 500 BGN
8 010 BGN
Cash receipts from repayment of advances and loans made to related parties
684,000 BGN
10 795 BGN
Proceeds from sales of investment property
- BGN
1 952 BGN
Cash flows from (used in) financing activities [abstract]
Proceeds from non-current borrowings
2 163 BGN
16 834 BGN
Repayments of non-current borrowings
20 029 BGN
19 405 BGN
Proceeds from current borrowings
12,000 BGN
19 554 BGN
Repayments of current borrowings
59 072 BGN
27 145 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.